As of 2025-07-07, the Fair Value of Lincoln Pharmaceuticals Ltd (LINCOLN.NS) is 442.21 INR. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 562.10 INR, the upside of Lincoln Pharmaceuticals Ltd is -21.33%.
With the market price of 562.10 INR and our fair value calculation, Lincoln Pharmaceuticals Ltd (LINCOLN.NS) is not a good investment. Investing in LINCOLN.NS stocks now will result in a potential loss of 21.33%.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | 5Y Avg | |
| Net income | 622.20 | 693.60 | 728.99 | 933.05 | 823.46 | 760.26 |
| YoY growth | 20.96% | 11.48% | 5.10% | 27.99% | -11.74% | 10.76% |
| Market Cap (mil) | 11,258.86 |
| P/E | 13.67x |
| Forward P/E | 10.06x |
| EPS | 41.11 |
| Avg earnings growth rate | 10.76% |
| TTM earnings | 823.46 |